Evaluating acute kidney injury in ICU patients
Incidence, Risk Factors, and Outcomes for Acute Kidney Injury in Intensive Care Patients: a Prospective Observational Study
Haseki Training and Research Hospital · NCT05970952
This study looks at how common kidney problems are in ICU patients and what factors might contribute to them, to help improve care for those who are critically ill.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 159 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Haseki Training and Research Hospital (other) |
| Locations | 1 site (Istanbul) |
| Trial ID | NCT05970952 on ClinicalTrials.gov |
What this trial studies
This prospective observational study aims to assess the incidence, risk factors, and outcomes associated with acute kidney injury (AKI) in critically ill patients admitted to the intensive care unit (ICU). It will include all adult patients who stay in the ICU for 48 hours or more, collecting data on demographics, length of stay, reasons for ICU admission, and other relevant health factors. The study will be conducted at the Health Science University Haseki Research and Training Hospital in Istanbul, Turkey, following ethical guidelines and obtaining informed consent from participants or their families.
Who should consider this trial
Good fit: Ideal candidates for this study are adult patients admitted to the ICU for 48 hours or more.
Not a fit: Patients with end-stage renal disease, existing AKI at ICU admission, or a history of renal transplantation will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve understanding of AKI in ICU patients, potentially leading to better prevention and management strategies.
How similar studies have performed: Other studies have explored AKI in ICU settings, indicating that this area of research is significant and has shown promising results in understanding risk factors and outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All adult patients admitted to the ICU with a stay of 48 h or more Exclusion Criteria: * Patients with missing data, end-stage renal disease, existence of AKI at the time of ICU admission or history of renal transplantation will be excluded from the study. Patients that were readmitted to the ICU within 48 h will reunited with the first admission and be considered as one admission for the analysis.
Where this trial is running
Istanbul
- Health Science University, Haseki Training and Research Hospital — Istanbul, Turkey (RECRUITING)
Study contacts
- Study coordinator: Sinan Uzman, Assoc. prof.
- Email: drsinanuzman@yahoo.com
- Phone: +905055645271
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Acute Renal Injury, Critical Illness, acute renal injury, intensive care unit